Insulin autoimmune syndrome during the administration of clopidogrel

J Diabetes. 2016 Jul;8(4):588-9. doi: 10.1111/1753-0407.12385. Epub 2016 Mar 16.

Authors

Eijiro Yamada¹, Shuichi Okada¹, Tsugumichi Saito¹, Aya Osaki¹, Atushi Ozawa¹, Masanobu Yamada¹

Affiliation

¹ Department of Medicine and Molecular Science, Gunma University Graduate School of Medicine, Gunma, Japan.

PMID: 26847582
DOI: 10.1111/1753-0407.12385

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Aged, 80 and over
Autoantibodies / blood
Autoantibodies / immunology
Autoimmune Diseases / blood
Autoimmune Diseases / chemically induced*
Autoimmune Diseases / immunology
Blood Glucose / metabolism
Clopidogrel
Glycated Hemoglobin / metabolism
Humans
Hypoglycemia / blood
Hypoglycemia / chemically induced*
Hypoglycemia / immunology
Insulin Antibodies / blood
Insulin Antibodies / immunology*
Male
Molecular Structure
Platelet Aggregation Inhibitors / adverse effects
Platelet Aggregation Inhibitors / chemistry
Syndrome
Ticlopidine / adverse effects
Ticlopidine / analogs & derivatives*
Ticlopidine / chemistry

Substances

Autoantibodies
Blood Glucose
Glycated Hemoglobin A
Insulin Antibodies
Platelet Aggregation Inhibitors
Clopidogrel
Ticlopidine